Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway

Xue Hu(Wuhan University), Yingan Jiang(Wuhan University)
Frontiers in Pharmacology
April 29, 2021
Cited by 24


Related Papers